Key Takeaways STXS gains FDA 510(k) clearance for GenesisX, its next-generation endovascular robotics system.GenesisX removes installation hurdles with compact design, standard power use, and no structural changes.STXS begins a limited U.S. and Europe launch while expanding catheter options and imaging integration.Stereotaxis (STXS) recently secured FDA 510(k) clearance for GenesisX, its next-generation robotic system designed to make endovascular surgical robotics far more accessible. The approval marks a ...